SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSVST.L Regulatory News (SVST)

  • There is currently no data for SVST

Offer Update

10 Dec 2007 07:01

OAO Severstal10 December 2007 10 December 2007 RECOMMENDED REVISED CASH OFFER BY CENTROFERVE LIMITED A WHOLLY OWNED SUBSIDIARY OF SEVERSTAL FOR CELTIC RESOURCES HOLDINGS PLC OFFER UNCONDITIONAL AS TO ACCEPTANCES Centroferve, a wholly owned subsidiary of Severstal, announces that, as at 3.00p.m. on Friday 7 December 2007, acceptances of the Offer had been received inrespect of 45,294,217 Celtic Shares (representing approximately 81.1% of theCeltic Shares to which the Offer relates) and that, accordingly, the Offer isunconditional as to acceptances. If the Offer is declared unconditional in all respects, Celtic Shareholders whohave accepted or accept the Offer while it remains open for acceptance willreceive aggregate cash consideration of £2.90 per Celtic Share becauseCentroferve has received acceptances of the Offer in respect of 80% in value ofthe Celtic Shares for which the Offer was made, and the contingent cashconsideration described in the Revised Offer Document has therefore becomepayable. Having received acceptances of the Offer in respect of 80% of the Celtic Sharesto which the Offer relates, if the Offer is declared unconditional in allrespects Centroferve intends to exercise its right pursuant to the provisions ofSection 204 of the Companies Act 1963 to acquire the remaining Celtic Shares towhich the Offer relates on the same terms as the Offer. Centroferve did not hold any Celtic Shares before the commencement of the OfferPeriod and has not acquired or agreed to acquire any Celtic Shares during theOffer Period. Prior to the Offer Period, Bluecone, a company owned by Severstal, acquired12,281,946 Celtic Shares, and during the Offer Period (but before the OriginalOffer was made) Bluecone acquired a further 4,301,056 Celtic Shares. As aresult, Bluecone owns 16,583,002 Celtic Shares representing approximately 29.7%of the issued share capital of Celtic, and the acceptances referred to aboveinclude an acceptance of the Offer by Bluecone in respect of all of the CelticShares held by Bluecone. Other than the Celtic Shares held or acquired by Bluecone, no party acting inconcert with Centroferve held before the commencement of the Offer Period, oracquired or agreed to acquire during the Offer Period, any Celtic Shares. Terms defined in the Revised Offer Document dated 20 November 2007 have the samemeaning in this announcement unless otherwise stated. The Offer remains open for acceptance until 3.00pm (Dublin time) on 28 December2007. Enquiries: Centroferve Tel: +7 495 9810 910 ext.6633 Roman Deniskin Nikolai Zelenski Morgan Stanley & Co. Limited Tel: +44 20 7425 8000 Peter Bacchus Arash Mahdaviani FD London Tel: +44 207 831 3113 Jon Simmons Ben Brewerton The directors of Centroferve and the directors of Severstal acceptresponsibility for the information contained in this announcement. To the bestof the knowledge and belief of the directors of Centroferve and the directors ofSeverstal (who have taken all reasonable care to ensure that such is the case),the information contained in this announcement for which they acceptresponsibility is in accordance with the facts and does not omit anything likelyto affect the import of such information. Morgan Stanley & Co. Limited ("Morgan Stanley") is acting exclusively forCentroferve and Severstal Resurs and no one else in connection with the Offerand Morgan Stanley will not regard any other person as a client in relation tothe Offer and will not be responsible to anyone other than Centroferve andSeverstal Resurs for providing the protections afforded exclusively to itsclients or for providing advice in relation to the Offer, the contents of thisannouncement or any transaction or arrangement referred to herein. The Offer will not be made, directly or indirectly, in or into any jurisdictionwhere it would be unlawful to do so, or by use of the mails, or by any means orinstrumentality (including, without limitation, telephonically orelectronically) of interstate or foreign commerce, or by any facility of anational securities exchange of any jurisdiction where it would be unlawful todo so, and the Offer will not be capable of acceptance by any such means,instrumentality or facility from or within any jurisdiction where it would beunlawful to do so. Accordingly, copies of this announcement and all otherdocuments relating to the Offer are not being, and must not be, mailed orotherwise forwarded, distributed or sent in, into or from any jurisdiction whereit would be unlawful to do so. Persons receiving such documents (including,without limitation, nominees, trustees and custodians) should observe theserestrictions. Failure to do so may invalidate any related purported acceptanceof the Offer. Notwithstanding the foregoing restrictions, Centroferve reservesthe right to permit the Offer to be accepted if, in its sole discretion, it issatisfied that the transaction in question is exempt from or not subject to thelegislation or regulation giving rise to the restrictions in question. This announcement does not constitute an offer to sell or an invitation topurchase or the solicitation of an offer to purchase or subscribe for anysecurities. Any response in relation to the Offer should be made only on thebasis of the information contained in the Revised Offer Document or any documentby which the Offer is made. Any person who is a holder of 1% or more of the Celtic Shares may havedisclosure obligations under Rule 8.3 of the Takeover Rules, effective from thedate of the commencement of the Offer Period. The Offer will be made in the United States pursuant to an exemption from the UStender offer rules provided by Rule 14d-1(c) under the US Exchange Act. Notice to US holders of Celtic Shares: The Offer will be made for the securities of an Irish public limited companywhose shares are listed on the AIM market in the UK and is subject to Irish andUK disclosure requirements, which are different from those of the United States.The Offer will be made in the United States pursuant to applicable US tenderoffer rules and otherwise in accordance with the requirements of the IrishTakeover Rules. Accordingly, the Offer will be subject to disclosure and otherprocedural requirements, including with respect to withdrawal rights, offertimetable, settlement procedures and timing of payments that are different fromthose applicable under US domestic tender offer procedures and law. The receipt of cash pursuant to the Offer by a US holder of Celtic Shares may bea taxable transaction for US federal income tax purposes and under applicable USstate and local, as well as foreign and other tax laws. Each holder of CelticShares is urged to consult his independent professional adviser immediatelyregarding the tax consequences of acceptance of the Offer. It may be difficult for US holders of Celtic Shares to enforce their rights andany claim arising out of the US federal securities laws, since Centroferve andCeltic are located in non-US jurisdictions, and some or all of their officersand directors may be residents of non-US jurisdictions. US holders of CelticShares may not be able to sue a non-US company or its officers or directors in anon-US court for violations of the US securities laws. Further, it may bedifficult to compel a non-US company and its affiliates to subject themselves toa US court's judgement. In accordance with normal Irish and UK practice and pursuant to Rule 14e-5(b) ofthe US Exchange Act, Centroferve or its nominees, or its brokers (acting asagents), may from time to time make certain purchases of, or arrangements topurchase, Celtic Shares outside the United States, other than pursuant to theOffer, before or during the period in which the Offer remains open foracceptance. These purchases may occur either in the open market at prevailingprices or in private transactions at negotiated prices. Any information aboutsuch purchases will be disclosed as required in Ireland and the UK, will bereported to a Regulatory Information Service of the UK Listing Authority andwill be available on the London Stock Exchange website, www.londonstockexchange.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Nov 20183:10 pmEQSPAO Severstal: Results of Extraordinary General Meeting
23rd Nov 20182:20 pmEQSPAO Severstal: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
7th Nov 201811:56 amEQSSeverstal to announce strategy update at its 2018 Capital Markets Day
6th Nov 20183:36 pmEQSPAO Severstal to hold Capital Markets Day 2018
19th Oct 20187:01 amEQSSeverstal reports Q3 & 9M 2018 financial results
18th Oct 20184:49 pmEQSDividend recommendation for three months ended 30 September 2018
16th Oct 201812:53 pmEQSNotice of Q3 2018 financial results
11th Oct 20187:01 amEQSSeverstal reports Q3 & 9M 2018 operational results
14th Sep 20182:56 pmEQSResults of Extraordinary General Meeting
23rd Aug 20181:19 pmEQSNotification of transaction by PDMR's_PCA
15th Aug 20183:30 pmEQSThe list of candidates nominated to the Board of Directors of Severstal
31st Jul 201810:12 amEQSNotification of transaction by PDMR's PCA
30th Jul 20183:50 pmEQSNotification of transaction by PDMR's PCA
30th Jul 201812:46 pmEQSOperations update
19th Jul 20187:01 amEQSSeverstal reports Q2 & H1 2018 financial results
19th Jul 20187:01 amEQSSeverstal reports Q2 & H1 2018 operational results
18th Jul 20186:15 pmEQSDividend recommendation for three months ended 30 June 2018
17th Jul 20181:08 pmEQSNotice of Q2 2018 financial and operational results
13th Jul 20188:02 amEQSPAO Severstal: Notification of transaction by PDMR's PCA
8th Jun 20184:45 pmRNSNotification of transaction by PDMR's PCA
8th Jun 20184:18 pmRNSResults of the Annual General Meeting
8th Jun 20181:50 pmRNSDirector/PDMR Shareholding
29th May 20187:00 amRNSSeverstal's strategic update
24th May 20187:12 amRNSNotification of transactions by PDMR
23rd Apr 201812:09 pmRNSManagement Share Dealing Notification
17th Apr 20187:04 amRNSSeverstal reports Q1 2018 financial results
16th Apr 20184:47 pmRNSSeverstal amends the dividend policy
16th Apr 20184:36 pmRNSDividend recommendation and the Agenda for the AGM
16th Apr 20187:40 amRNSNotice of Q1 2018 financial results
10th Apr 20187:00 amRNSSeverstal reports Q1 2018 operational results
20th Mar 20188:26 amRNSSeverstal paid off Eurobonds 2018
2nd Feb 20181:26 pmRNSSeverstal publishes 2017 Annual Report
2nd Feb 20187:39 amRNSSeverstal announces 2018 CAPEX programme
2nd Feb 20187:00 amRNSSeverstal reports Q4 & FY 2017 financial results
1st Feb 20184:26 pmRNSRecommended Dividend and Date of AGM
30th Jan 201812:44 pmRNSNotice of Q4 2017 financial results
19th Jan 20187:06 amRNSSeverstal reports Q4 & FY 2017 operational results
27th Nov 201712:59 pmRNSResults of Extraordinary General Meeting
14th Nov 201712:26 pmRNSNotification of transactions by PDMR
9th Nov 20177:00 amRNSPLACING OF ORDINARY SHARES IN PAO SEVERSTAL
30th Oct 20179:27 amRNSSeverstal paid off Eurobonds of $594 mln
18th Oct 20177:00 amRNSSeverstal reports Q3 & 9M 2017 financial results
17th Oct 20174:28 pmRNSDividend recommendation
12th Oct 201710:00 amRNSNotice of Q3 2017 financial results
10th Oct 20177:04 amRNSSeverstal reports Q3 & 9M 2017 operational results
25th Sep 20177:34 amRNSThe repayment of Convertible Bonds due 2017
18th Sep 20174:20 pmRNSResults of Extraordinary General Meeting
20th Jul 20177:00 amRNSSeverstal reports Q2 and H1 2017 financial results
20th Jul 20177:00 amRNSSeverstal acquires the debt of Yakovlevsky mine
19th Jul 20175:10 pmRNSDividend recommendation for first six months 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.